[ 1 ] Diaz JH. Global incidence of rhabdomyolysis after cooked seafood consumption (Haff disease). Clin Toxicol 2015;53(5):421–6. 链接1

[ 2 ] Buchholz U, Mouzin E, Dickey R, Moolenaar R, Sass N, Mascola L. Haff disease: from the Baltic Sea to the US shore. Emerg Infect Dis 2000;6(2):192–5. 链接1

[ 3 ] Taniyama S, Sagara T, Nishio S, Kuroki R, Asakawa M, Noguchi T, et al. Survey of food poisoning incidents in Japan due to ingestion of marine boxfish and their toxicity. Shokuhin Eiseigaku Zasshi 2009;50(5):270–7. Japanese. 链接1

[ 4 ] Huang X, Li Y, Huang Q, Liang J, Liang C, Chen B, et al. A past Haff disease outbreak associated with eating freshwater pomfret in south China. BMC Public Health 2013;13(1):447. 链接1

[ 5 ] Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Intern Med 2007;18(2):90–100. 链接1

[ 6 ] Chan TY. The emergence and epidemiology of Haff disease in China. Toxins 2016;8(12):359. 链接1

[ 7 ] Dang K, Jiang S, Gao Y, Qian A. The role of protein glycosylation in muscle diseases. Mol Biol Rep 2022;49(8):8037–49. 链接1

[ 8 ] Paton B, Suarez M, Herrero P, Canela N. Glycosylation biomarkers associated with age-related diseases and current methods for glycan analysis. Int J Mol Sci 2021;22(11):5788. 链接1

[ 9 ] Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol 2019;15(6):346–66. 链接1

[10] Reiding KR, Ruhaak LR, Uh HW, El Bouhaddani S, van den Akker EB, Plomp R, et al. Human plasma N-glycosylation as analyzed by matrix-assisted laser desorption/ionization-fourier transform ion cyclotron resonance-MS associates with markers of inflammation and metabolic health. Mol Cell Proteomics 2017;16(2):228–42. 链接1

[11] Zhang Y, Jiao J, Yang P, Lu H. Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery. Clin Proteomics 2014;11(1):18. 链接1

[12] Adamczyk B, Tharmalingam T, Rudd PM. Glycans as cancer biomarkers. Biochim Biophys Acta 2012;1820(9):1347–53. 链接1

[13] Hart GW, Wells L. Glycoproteomics: making the study of the most structurally diverse and most abundant post-translational modifications more accessible to the scientific community. Mol Cell Proteomics 2021;20:100086. 链接1

[14] Gao X, Song X, Zuo R, Yang D, Ji C, Ji H, et al. Ionophore toxin maduramicin produces haff disease-like rhabdomyolysis in a mouse model. Int J Environ Res Public Health 2020;17(21):7882. 链接1

[15] Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010;17(7):1055–65. 链接1

[16] Anthony RM, Wermeling F, Ravetch JV. Novel roles for the IgG Fc glycan. Ann N Y Acad Sci 2012;1253(1):170–80. 链接1

[17] Cobb BA. The history of IgG glycosylation and where we are now. Glycobiology 2020;30(4):202–13. 链接1

[18] Wang X, Mathieu M, Brezski RJ. IgG Fc engineering to modulate antibody effector functions. Protein Cell 2018;9(1):63–73. 链接1

[19] Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol 2014;5:520. 链接1

[20] Van Helden PM, van den Berg HM, Gouw SC, Kaijen PH, Zuurveld MG, MauserBunschoten EP, et al. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A. Br J Haematol 2008;142 (4):644–52. 链接1

[21] Liu S, Cheng L, Fu Y, Liu BF, Liu X. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS. J Proteomics 2018;181:225–37. 链接1

[22] Liu X, Qiu H, Lee RK, Chen W, Li J. Methylamidation for sialoglycomics by MALDI-MS: a facile derivatization strategy for both a2,3- and a2,6-linked sialic acids. Anal Chem 2010;82(19):8300–6. 链接1

[23] Zhang Q, Feng X, Li H, Liu BF, Lin Y, Liu X. Methylamidation for isomeric profiling of sialylated glycans by nanoLC-MS. Anal Chem 2014;86 (15):7913–9. 链接1

[24] Liu S, Fu Y, Huang Z, Liu Y, Liu BF, Cheng L, et al. A comprehensive analysis of subclass-specific IgG glycosylation in colorectal cancer progression by nanoLCMS/MS. Analyst 2020;145(8):3136–47. 链接1

[25] Kang P, Mechref Y, Novotny MV. High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun Mass Spectrom 2008;22(5):721–34. 链接1

[26] Zhang Z, Westhrin M, Bondt A, Wuhrer M, Standal T, Holst S. Serum protein Nglycosylation changes in multiple myeloma. Biochim Biophys Acta, Gen Subj 2019;1863(5):960–70. 链接1

[27] Liu Y, Wang C, Wang R, Wu Y, Zhang L, Liu BF, et al. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer. J Proteomics 2018;181:160–9. 链接1

[28] Kao D, Danzer H, Collin M, Groß A, Eichler J, Stambuk J, et al. A monosaccharide residue is sufficient to maintain mouse and human IgG subclass activity and directs IgG effector functions to cellular Fc receptors. Cell Rep 2015;13 (11):2376–85. 链接1

[29] Liu S, Yu Y, Liu Y, Lin J, Fu Y, Cheng L, et al. Revealing the changes of IgG subclass-specific N-glycosylation in colorectal cancer progression by highthroughput assay. Proteomics Clin Appl 2021;15(2–3):e2000022. 链接1

[30] Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995;57 (1):289–300. 链接1

[31] Bladergroen MR, Reiding KR, Hipgrave Ederveen AL, Vreeker GC, Clerc F, Holst S, et al. Automation of high-throughput mass spectrometry-based plasma Nglycome analysis with linkage-specific sialic acid esterification. J Proteome Res 2015;14(9):4080–6. 链接1

[32] Liu S, Liu X. IgG N-glycans. Adv Clin Chem 2021;105:1–47. 链接1

[33] Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 2015;15(9):540–55. 链接1

[34] Pei P, Li XY, Lu SS, Liu Z, Wang R, Lu XC, et al. The emergence, epidemiology, and etiology of haff disease. Biomed Environ Sci 2019;32 (10):769–78. 链接1

[35] Stanley M, Chippa V, Aeddula NR, Quintanilla Rodriguez BS, Rhabdomyolysis AR. StatPearls. Treasure Island: StatPearls Publishing; 2022. 链接1

[36] Cabral BMI, Edding SN, Portocarrero JP, Lerma EV. Rhabdomyolysis. Dis Mon 2020;66(8):101015. 链接1

[37] Ahmad SC, Sim C, Sinert R. Elevated liver enzymes as a manifestation of haff disease. J Emerg Med 2019;57(6):e181–3. 链接1

[38] Florsheim EB, Sullivan ZA, Khoury-Hanold W, Medzhitov R. Food allergy as a biological food quality control system. Cell 2021;184(6):1440–54. 链接1

[39] Kostrzewa-Nowak D, Kubaszewska J, Nowakowska A, Nowak R. Effect of aerobic and anaerobic exercise on the complement system of proteins in healthy young males. J Clin Med 2020;9(8):2357. 链接1

[40] Dumic´ J, Cvetko A, Abramovic´ I, Šupraha Goreta S, Perovic´ A, Njire Braticˇevic´ M, et al. Changes in specific biomarkers indicate cardiac adaptive and antiinflammatory response of repeated recreational SCUBA diving. Front Cardiovasc Med 2022;9:855682. 链接1

[41] Nimmerjahn F, Ravetch JV. Four keys to unlock IgG. J Exp Med 2021;218(3): E20201753. 链接1

[42] Ohmi Y, Ise W, Harazono A, Takakura D, Fukuyama H, Baba Y, et al. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun 2016;7(1):11205. 链接1

[43] Liu J, Liu S, Huang Z, Fu Y, Fei J, Liu X, et al. Associations between the serum levels of PFOS/PFOA and IgG N-glycosylation in adult or children. Environ Pollut 2020;265(Pt A):114285. 链接1

[44] Nimmerjahn F, Ravetch JV. Translating basic mechanisms of IgG effector activity into next generation cancer therapies. Cancer Immun 2012;12:13. 链接1

[45] Gornik O, Pavic´ T, Lauc G. Alternative glycosylation modulates function of IgG and other proteins—implications on evolution and disease. Biochim Biophys Acta 2012;1820(9):1318–26. 链接1

[46] Sondermann P, Pincetic A, Maamary J, Lammens K, Ravetch JV. General mechanism for modulating immunoglobulin effector function. Proc Natl Acad Sci USA 2013;110(24):9868–72. 链接1

[47] Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 2013;13 (3):176–89. 链接1

[48] Li T, DiLillo DJ, Bournazos S, Giddens JP, Ravetch JV, Wang LX. Modulating IgG effector function by Fc glycan engineering. Proc Natl Acad Sci USA 2017;114 (13):3485–90. 链接1

[49] Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol 2018;333:65–79. 链接1

[50] Nishima W, Miyashita N, Yamaguchi Y, Sugita Y, Re S. Effect of bisecting GlcNAc and core fucosylation on conformational properties of biantennary complex-type N-glycans in solution. J Phys Chem B 2012;116(29):8504–12. 链接1

[51] Jennewein MF, Alter G. The immunoregulatory roles of antibody glycosylation. Trends Immunol 2017;38(5):358–72. 链接1

[52] Verhelst X, Dias AM, Colombel JF, Vermeire S, Van Vlierberghe H, Callewaert N, et al. Protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases. Gastroenterology 2020;158 (1):95–110. 链接1